新发1型和2型糖尿病早期肝脏能量代谢与脂质含量的变化
这项前瞻性研究纳入30例1型糖尿病和37例2型糖尿病初诊患者,用磁共振波谱在初诊及5年后测肝细胞脂质(HCL)、γATP和无机磷酸盐(Pi),并用高胰岛素-正常血糖钳夹评估胰岛素敏感性。结果显示2型糖尿病组HCL几乎翻倍、NAFLD患病率从38%升至70%,而1型糖尿病组HCL不变但γATP下降10%且与糖化血红蛋白负相关。
要点
- 2型糖尿病初诊5年内肝脂翻倍,NAFLD患病率由38%升至70%
- 肝脂变化与脂肪组织体积及胰岛素抵抗相关(r=0.50和r=0.44)
- 1型糖尿病肝脂不变但γATP降10%,与糖化血红蛋白负相关
核心结论
- 2型糖尿病早期肝细胞脂质快速增加,可能与脂肪组织体积增大和胰岛素抵抗导致肝脏线粒体适应不良有关。
- 1型糖尿病磷代谢物下降,可能与外源性胰岛素供给有关。
研究设计与样本
- 前瞻性研究纳入初诊1型糖尿病30例和2型糖尿病37例志愿者。
- 初诊及5年后用1H/31P磁共振波谱测肝细胞脂质、γATP和无机磷酸盐浓度并评估脂肪组织体积。
- 用高胰岛素-正常血糖钳夹评估胰岛素敏感性。
主要发现
- 初诊时2型糖尿病组肝细胞脂质和脂肪组织体积高于1型糖尿病组,全身胰岛素敏感性更低,尽管血糖控制相当。
- 初诊时NAFLD在2型糖尿病组为38%、1型糖尿病组为7%。
- 5年后内脏脂肪组织仅在2型糖尿病组增加,该组肝细胞脂质几乎翻倍(p<0.001),NAFLD患病率达70%(独立于糖尿病治疗)。
- 肝细胞脂质变化与脂肪组织体积和胰岛素抵抗相关(r=0.50和r=0.44,均p<0.05)。
- 无机磷酸盐在2型糖尿病组和1型糖尿病组分别下降17%和10%(p<0.05);1型糖尿病组肝细胞脂质不变,γATP下降10%且与糖化血红蛋白负相关(r=-0.56,p<0.05)。
临床怎么用
- 2型糖尿病初诊后5年内应关注肝脂积累与NAFLD发生,尤其在内脏脂肪增加和胰岛素抵抗明显者。
- 1型糖尿病需关注肝细胞能量代谢下降,γATP降低与糖化血红蛋白相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) is associated with abnormal mitochondrial capacity. While oxidative capacity can be increased in steatosis, hepatic ATP decreases in long-standing diabetes. However, longitudinal studies on diabetes-related NAFLD and its relationship to hepatic energy metabolism are lacking. METHODS: This prospective study comprised volunteers with type 1 (T1DM, n = 30) and type 2 (T2DM, n = 37) diabetes. At diagnosis and 5 years later, we used 1H/31P magnetic resonance spectroscopy to measure hepatocellular lipid (HCL), γATP and inorganic phosphate (Pi) concentrations, and to assess adipose tissue volumes. Insulin sensitivity was assessed by hyperinsulinemic-euglycemic clamps. RESULTS: At diagnosis, individuals with T2DM had higher HCL and adipose tissue volumes, but lower whole-body insulin sensitivity than those with T1DM, despite comparable glycemic control. NAFLD was present in 38% of individuals with T2DM and 7% with T1DM. After 5 years, visceral adipose tissue only increased in individuals with T2DM, while HCL almost doubled in this group (p <0.001), resulting in a 70% prevalence of NAFLD (independent of diabetes treatment). Changes in HCL correlated with adipose tissue volume and insulin resistance (r = 0.50 and r = 0.44, both p <0.05). Pi decreased by 17% and 10% in individuals with T2DM and T1DM (p <0.05), respectively. In T1DM, HCL did not change, whereas γATP decreased by 10% and correlated negatively with glycated hemoglobin (r = -0.56, p <0.05). CONCLUSIONS: The rapid increase in HCL during the early course of T2DM likely results from enlarging adipose tissue volume and insulin resistance in response to impaired hepatic mitochondrial adaptation. The decrease of phosphorus metabolites in T1DM may be due to pharmacological insulin supply. LAY SUMMARY: Previous studies suggested that the impaired function of mitochondria, the power plants of cells, can promote fatty liver and type 2 diabetes mellitus. This study now shows that during the first 5 years of type 2 diabetes the increase in body fat content rapidly leads to a doubling of liver fat content, whereas the energy metabolism of the patients' livers progressively declines. These data suggest that fat tissue mass and liver mitochondria have an important role in the development of fatty liver disease in humans with diabetes. CLINICAL TRIAL NUMBER: NCT01055093.
引用
- Kupriyanova Y, Zaharia OP, Bobrov P, et al. Early changes in hepatic energy metabolism and lipid content in recent-onset type 1 and 2 diabetes mellitus. J Hepatol. 2020. PMID: 33259845. doi:10.1016/j.jhep.2020.11.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。